13F
← All fund report cards

SALEM INVESTMENT COUNSELORS INC

13F equity value
$2.8B
Positions
1,148
Top 10 concentration
47.9%
Quarters / total new picks
32 / 1,250
13F equity value over time
$0M$2B$4B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = 0.69, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.4%
t-stat
0.69
Quarterly win rate
50%
Annualized excess
-0.5%
$1 → follow vs universe
$2.01 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.97320180630: follow 0.92820180930: follow 1.01220181231: follow 1.10520190331: follow 1.10820190630: follow 1.18520190930: follow 1.52620191231: follow 1.30520200331: follow 1.63020200630: follow 1.81720200930: follow 2.06020201231: follow 1.90720210331: follow 1.98820210630: follow 2.07620210930: follow 1.81720211231: follow 1.60120220331: follow 1.71420220630: follow 1.59720220930: follow 1.61120221231: follow 1.50220230331: follow 1.53220230630: follow 1.46020230930: follow 1.65120231231: follow 1.65620240331: follow 1.60920240630: follow 1.84020240930: follow 1.77820241231: follow 1.69420250331: follow 1.89420250630: follow 2.05220250930: follow 2.20820251231: follow 2.010 0.84 1.61 2.39 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1148 · 2026 Q1

Ticker Value Weight QoQ
LOW $329M
11.9%
HOLD
NVDA $243M
8.8%
TRIM
MSFT $145M
5.3%
HOLD
GOOG $142M
5.1%
HOLD
META $90M
3.3%
HOLD
PLTR $85M
3.1%
TRIM
GOOGL $77M
2.8%
HOLD
LLY $72M
2.6%
HOLD
JPM $71M
2.6%
HOLD
MU $69M
2.5%
HOLD
PEP $44M
1.6%
HOLD
JNJ $43M
1.6%
HOLD
WMT $41M
1.5%
HOLD
GRBK $41M
1.5%
HOLD
CAT $35M
1.3%
HOLD
NU $30M
1.1%
HOLD
ISRG $29M
1.1%
HOLD
ABBV $29M
1.0%
HOLD
TSM $28M
1.0%
HOLD
V $25M
0.9%
HOLD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.